We are proud to announce that Bioingentech has successfully dispatched a new international shipment of Real-Time PCR diagnostic kits for Nipah Virus (NiV) to our partners in Cambodia. This delivery supports regional preparedness efforts against emerging zoonotic threats in Southeast Asia.
Nipah virus remains a high-priority pathogen due to its epidemic potential, high case-fatality rate, and impact on both human and animal health. This shipment reinforces our commitment to supporting advanced molecular diagnostics in regions where early detection is critical for outbreak containment.
Kits Included in This Shipment
🔹 Nipah Virus (NiV) — Oneq-VH139-100R
A highly sensitive and specific real-time RT-qPCR assay designed for the detection of Nipah virus RNA in clinical and research samples.
- Optimized primers and probe targeting conserved regions of the NiV genome
- Validated for rapid turnaround and high analytical sensitivity
- Suitable for surveillance, outbreak response, and epidemiological monitoring
- Compatible with standard real-time PCR platforms
This kit supports laboratories conducting molecular surveillance in both human and veterinary contexts, aligned with One Health principles.
Strengthening Surveillance in Southeast Asia
Cambodia is located within a region where zoonotic spillover events remain a public health concern. By equipping diagnostic laboratories with validated molecular tools, we contribute to:
- Early case identification
- Rapid outbreak containment
- Cross-border epidemiological monitoring
- Integration of veterinary and human health diagnostics
Our collaboration with Cambodian institutions reflects a shared commitment to proactive pathogen surveillance and laboratory capacity building.
Manufactured Under Certified Quality Standards
All Bioingentech molecular diagnostic kits are manufactured in Chile under internationally recognized quality management systems:
- ISO 9001:2015 — Quality Management Systems
- ISO 13485:2016 — Medical Device Quality Assurance
These certifications ensure traceability, reproducibility, and compliance with international regulatory standards.
Acknowledgments
We extend our sincere appreciation to our production, logistics, and quality control teams for their coordinated execution of this shipment. We also thank our Cambodian partners for their trust in Bioingentech’s molecular diagnostic technology.
Together, we continue advancing global preparedness against emerging infectious diseases through reliable and high-performance PCR solutions.